tomeko

POMGNT2-related limb-girdle muscular dystrophy R24

Just diagnosed with POMGNT2-related limb-girdle muscular dystrophy R24?

You are not alone. Here is where to start: learn the basics, find a specialist or center that sees POMGNT2-related limb-girdle muscular dystrophy R24, look for clinical trials, and connect with others living with it — all in one place.

Open the full POMGNT2-related limb-girdle muscular dystrophy R24 hub →

Overview

POMGNT2-related limb-girdle muscular dystrophy R24 is a rare condition. Also known as POMGNT2-related LGMD R24, POMGNT2-related muscular dystrophy, LGMD type R24, Limb-girdle muscular dystrophy type R24. Tomeko brings together the specialists, research, clinical trials, treatments and community for POMGNT2-related limb-girdle muscular dystrophy R24 so you can go from overwhelmed to oriented. For authoritative medical detail, see the reference sources below.

Identifiers: ORPHA:565899 · OMIM 618135 · ICD-10 G71.0 · GARD 0022271

Find care for POMGNT2-related limb-girdle muscular dystrophy R24

Authoritative references for POMGNT2-related limb-girdle muscular dystrophy R24

Common questions

I was just diagnosed with POMGNT2-related limb-girdle muscular dystrophy R24 — what should I do first?

Start by learning the basics from an authoritative source, find a specialist or center that sees POMGNT2-related limb-girdle muscular dystrophy R24, and connect with a patient organization. Tomeko brings these together on one hub.

Where can I find a specialist for POMGNT2-related limb-girdle muscular dystrophy R24?

Use Tomeko's specialist and Centers-of-Excellence directories to find clinicians who treat POMGNT2-related limb-girdle muscular dystrophy R24, filtered to your area.

Are there clinical trials for POMGNT2-related limb-girdle muscular dystrophy R24?

Tomeko shows live, recruiting studies for POMGNT2-related limb-girdle muscular dystrophy R24 from ClinicalTrials.gov on the hub.

Informational only — not medical advice. Always consult a qualified clinician. Provider and reference data from public sources (NIH GARD, Orphanet, OMIM, HPO, MONDO, ClinicalTrials.gov, CMS NPPES). © Tomeko · tomekohealth.com